Register entry
CALL INC. (dba Rochester Pharmaceuticals)
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Adapalene | Adapalene | swab, topical | 49908-118ANDA |
Compare
Other companies listing adapalene
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Glenmark Pharmaceuticals Inc., USA9 sites · 383 NDC
- Kenvue Brands LLC7 sites · 564 NDC
- P & L Development, LLC5 sites · 119 NDC
- Medichem SA5 sites · 43 NDC
- AARTI PHARMALABS LIMITED3 sites · 34 NDC
- Arch Pharmalabs Limited3 sites · 12 NDC
- Padagis Israel Pharmaceuticals Ltd2 sites · 236 NDC
- Darmerica, LLC1 site · 212 NDC
- Maithri Drugs Private Limited1 site · 80 NDC
Enquiry
Common questions
- Is CALL INC. (dba Rochester Pharmaceuticals) FDA approved?
- CALL INC. (dba Rochester Pharmaceuticals) holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does CALL INC. (dba Rochester Pharmaceuticals) make?
- 1 product is listed under CALL INC. (dba Rochester Pharmaceuticals) in the openFDA NDC Directory, most often as swab. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.